The role of spin-phonon coupling in enhanced desorption kinetics of antioxidant flavonols from magnetic nanoparticles aggregates
Source abstract
Abstract
An important criterion in the evaluation of drug delivery systems based on nanoparticles is the drug release kinetics. From numerous published works, it is obvious that the fraction of the released drug as a function of time shows qualitatively the same behaviour, even when the release is assisted by an external force. In this study a series of experiments has been performed on a system that can be considered as the simplest drug delivery system. It consists only of uncoated/unprotected superparamagnetic magnetite nanoparticles in the form of mesoporous aggregates and adsorbed flavonols (quercetin, myricetin, or myricitrin). The simultaneous utilization of external permanent and oscillating magnetic fields remarkably accelerated the flavonol release. There is no a specific pulling force that eventually causes the rupture of the bonds between the molecules and the particle surface, i.e. the detachment of an individual molecule is thermally activated. The adsorption of molecules onto nanoparticles follows almost without delay quick changes in the field-induced motion of the nanoparticles, and they are subject to more frequent collisions with the surrounding solvent molecules. The barrier fluctuations occur due to the magnetic field dependence of the nanoparticle phonon spectra, to which the adsorbed flavonol molecule vibrations are strongly coupled. The phonon frequencies and phonon damping of a ferromagnetic nanoparticle are actually affected by the magnetic field through the spin-phonon coupling. The rate of release (spontaneous or forced) is invariably a first-order process, which can be considered a basic property of a broad class of drug nanodelivery systems.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnetic and Electromagnetic Effects · Spectroscopy and Quantum Chemical Studies · Biofield Effects and Biophysics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Inorganic nanoparticles for biomedicine, where materials scientists meet medical research10.1016/j.mattod.2015.07.004 ↗
2. Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications10.3390/molecules18077533 ↗
3. HEPES-involved hydrothermal synthesis of Fe3O4 nanoparticles and their biological application10.1039/C4RA12536C ↗
4. Magnetofection, enhancing and targeting gene delivery by magnetic force in vitro and in vivo10.1038/sj.gt.3301624 ↗
5. Clinical applications of magnetic drug targeting10.1006/jsre.2000.6030 ↗
6. Effect of an oscillating magnetic field on the release properties of magnetic collagen gels10.1021/la060280h ↗
7. Influence of alternating and static magnetic fields on drug release from hybrid hydrogels containing magnetic nanoparticles10.4236/jbnb.2014.52014 ↗
8. Magnetic field responsive drug release from magnetoliposomes in biological fluids10.1039/C5TB02191J ↗
9. Modeling drug-carrier interaction in the drug release from nanocarriers10.1155/2011/370308 ↗
10. General method for the quantification of drug loading and release kinetics of nanocarriers10.1016/j.ejpb.2016.12.015 ↗
11. Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice10.1016/j.cbi.2015.01.030 ↗
12. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo10.1002/anie.200800857 ↗
13. Monodisperse mesoporous superparamagnetic single-crystal magnetite nanoparticles for drug delivery10.1016/j.biomaterials.2008.12.042 ↗
14. Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells10.1016/j.biopha.2014.12.012 ↗
15. Magnetically triggered drug release from nanoparticles and its applications in anti-tumor treatment10.1080/10717544.2016.1256001 ↗
16. Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity10.1021/nn103213y ↗
17. Magnetic nanoparticles for a new drug delivery system to control quercetin releasing for cancer chemotherapy10.1007/s11051-011-0559-9 ↗
18. Quercetin conjugated superparamagnetic magnetite nanoparticles for in-vitro analysis of breast cancer cell lines for chemotherapy applications10.1016/j.jcis.2014.08.064 ↗
19. Kinetics of ibuprofen release from magnetic nanoparticles coated with chitosan10.1007/s11094-016-1475-1 ↗
20. Towards nanomedicines of the future, Remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields10.1016/j.jconrel.2015.09.038 ↗
21. Modeling drug release from functionalized magnetic nanoparticles actuated by non-heating low frequency magnetic field10.1007/s11051-017-3754-5 ↗
22. Magnetic iron oxide nanoparticles, synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications10.1021/cr068445e ↗
23. Enhanced in vitro and in vivo cellular imaging with green tea coated water-soluble iron oxide nanocrystals10.1021/am508404t ↗
24. Synthesis of superparamagnetic Fe3O4 nanoparticles coated with green tea polyphenols and their use for removal of dye pollutant from aqueous solution10.1016/j.jece.2017.04.022 ↗
25. Preparation and characterization of microemulsions of myricetin for improving its antiproliferative, antioxidative activity and oral bioavailability10.1021/acs.jafc.6b02184 ↗
26. Brownian motion in a field of force and diffusion model of chemical reactions10.1016/S0031-8914(40)90098-2 ↗
27. Controlled delivery of drugs adsorbed onto porous Fe3O4 structures by application of AC/DC magnetic fields10.1016/j.micromeso.2015.12.032 ↗
28. Magnetic Magnetite (Fe3O4) Nanoparticle Synthesis and Applications for Lead (Pb2+) and Chromium (Cr6+) Removal from Water10.1016/j.jcis.2015.12.008 ↗
29. Aggregation and sedimentation of magnetite nanoparticle clusters
30. Pair correlation in a ferromagnetic colloid
31. Deprotonation mechanism and acidity constants in aqueous solution of flavonols, a combined experimental and theoretical study10.1021/jp4049617 ↗
32. On the stability of the bioactive flavonoids quercetin and luteolin under oxygen-free conditions10.1007/s00216-011-5504-3 ↗
33. Transformation of γ-FeO(OH) to Fe3O4 by adsorption of iron(II) ion on γ-FeO(OH)10.1039/DT9830000189 ↗
34. Quercetin
35. Solid-State and Solution Characterization of Myricetin10.1208/s12249-015-0329-6 ↗
36. Comptox https://comptox.epa.gov/dashboard/dsstoxdb/results?search=DCYOADKBABEMIQ#toxval. Accessed 14 April 2018.
37. Development of biodegradable nanoparticles for delivery of quercetin10.1016/j.colsurfb.2010.06.002 ↗
38. Magnetic fluids10.1070/PU1974v017n02ABEH004332 ↗
39. Low-gradient magnetophoresis through field-induced reversible aggregation10.1021/jp0755286 ↗
40. Kotkin · 1971
41. Vibrations of a molecule in an external force field10.1073/pnas.1721498115 ↗
42. Theoretical study of phonon spectra in ferromagnetic nanoparticles10.1016/j.physleta.2007.07.025 ↗
43. Dynamics of magnetic nanoparticle in a viscous liquid10.1063/1.4737126 ↗
44. Mean exit times over fluctuating barriers10.1016/0375-9601(89)90414-3 ↗
45. Changes in transition rates due to barrier fluctuations, the case of dichotomic noise10.1016/0375-9601(93)90500-Y ↗